Home›Trial›NCT07443202
🔬NCT07443202Phase 2ENROLLING BY INVITATION

Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Study Summary

To evaluate lotilaner treatment in patients with ocular rosacea.

Conditions
Ocular Rosacea
Interventions / Drugs
lotilanerVehicle
View on ClinicalTrials.gov ↗
Sponsor
TARS
Tarsus Pharmaceuticals, Inc.
Biotech / Pharma
D44/100
Study Details
Enrollment155 participants
Primary Completion—
Lead SponsorTarsus Pharmaceuticals, Inc.
Data Retrieved2026-06-17 02:58:25.715412+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.